Great Point Partners as of Dec. 31, 2013
Portfolio Holdings for Great Point Partners
Great Point Partners holds 28 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hyperion Therapeutics | 11.6 | $16M | 811k | 20.22 | |
| Pain Therapeutics | 9.6 | $14M | 2.8M | 4.86 | |
| Furiex Pharmaceuticals | 9.5 | $13M | 320k | 42.01 | |
| Sunshine Heart | 6.3 | $8.9M | 916k | 9.71 | |
| Ambit Bioscience | 5.0 | $7.1M | 733k | 9.64 | |
| Ocera Therapeutics | 4.8 | $6.9M | 528k | 12.99 | |
| Infinity Pharmaceuticals (INFIQ) | 4.4 | $6.2M | 451k | 13.81 | |
| Chemocentryx | 4.1 | $5.8M | 1.0M | 5.79 | |
| Nanosphere | 4.0 | $5.7M | 2.5M | 2.29 | |
| Aerie Pharmaceuticals | 3.9 | $5.5M | 308k | 17.96 | |
| AVEO Pharmaceuticals | 3.9 | $5.5M | 3.0M | 1.83 | |
| Veracyte (VCYT) | 3.6 | $5.1M | 354k | 14.50 | |
| Sophiris Bio | 3.6 | $5.1M | 1.4M | 3.70 | |
| Cynosure Cl A | 3.2 | $4.5M | 170k | 26.64 | |
| Alcobra | 3.2 | $4.5M | 250k | 18.00 | |
| HeartWare International | 3.1 | $4.4M | 47k | 93.90 | |
| Volcano Corporation | 3.1 | $4.4M | 200k | 21.85 | |
| Protalix BioTherapeutics | 2.7 | $3.9M | 1.0M | 3.89 | |
| D Horizon Pharma | 2.7 | $3.8M | 500k | 7.62 | |
| Chelsea Therapeutics International Put Option | 2.3 | $3.2M | 727k | 4.43 | |
| pSivida | 1.4 | $2.0M | 500k | 3.97 | |
| Avanir Pharmaceuticals Cl A New Call Option | 1.3 | $1.9M | 567k | 3.36 | |
| Mei Pharma Com New | 0.9 | $1.3M | 158k | 8.01 | |
| Combimatrix Corporation Com New | 0.6 | $849k | 369k | 2.30 | |
| Mast Therapeutics | 0.4 | $599k | 1.3M | 0.46 | |
| Streamline Health Solutions (STRM) | 0.4 | $586k | 84k | 6.98 | |
| Rockwell Medical Technologies | 0.3 | $418k | 40k | 10.45 | |
| Wright Med Group Right 03/01/2019 | 0.0 | $38k | 117k | 0.33 |
